A Spanish research team has achieved a significant preclinical breakthrough, developing a triple-drug therapy that completely eradicated aggressive...

Entropy Neurodynamics receives encouraging first results from a clinical trial of its psilocin therapy in Binge Eating Disorder.     ...

Entropy Neurodynamics receives encouraging first results from a clinical trial of its psilocin therapy in Binge Eating Disorder.     ...

Researchers at the Spanish National Cancer Research Centre (CNIO), led by Dr. Mariano Barbacid, have achieved a significant breakthrough in the...

UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors in a setting that...

FRIDAY, Jan. 30, 2026 — An already-approved immunotherapy drug can dramatically shrink — or even eliminate — tumors associated with...

New study suggests that an experimental peptide developed at the Hebrew University may reduce recurring seizures and support brain function by...

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering....

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering....

Combining artificial intelligence and nanoscale sensors, the research demonstrates a new approach that could potentially detect and distinguish...